# Nurix Therapeutics, Inc.: Form 8-K, filed May 21, 2024

- Company: [Nurix Therapeutics, Inc.](/companies/nrix.md) (CIK 1549595)
- Form: 8-K
- Filed: 2024-05-21
- Accepted by EDGAR: May 21, 2024, 07:06 ET
- Period: 2024-05-20
- Accession: 0001549595-24-000073
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1549595/000154959524000073/nrix-20240520.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1549595/000154959524000073/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1549595/000154959524000073/nrix-20240520.htm

Filed May 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001549595-24-000073. Last ingested by Listed: Nov 5, 2026, 13:59 ET. No prices; not investment advice.
